供者与亲属异基因造血干细胞移植长期存活者的克隆性造血
研究纳入42对供者-受者配对,中位随访16年,发现27.4%的参与者存在克隆性造血(CH),供者与受者分别为23.8%和31%。供者来源的CH可在受者体内植入并在部分病例中克隆增大,1例供受者均进展为骨髓增生异常综合征。
要点
- 亲属allo-HSCT供受者中CH发生率约27.4%,与供受者年龄相关
- 供者来源CH可植入受者,部分受者克隆大小增加
- CH克隆在髓系持续存在,B/T细胞穿透性不一
核心结论
- 亲属异基因造血干细胞移植长期存活者中克隆性造血常见,供者来源CH可在受者体内长期存在并出现克隆演变。
研究设计与样本
- 研究纳入42对供者-受者配对,中位随访16年(范围10-32年),检测克隆性造血并分析其分布与演变。
主要发现
- 84名参与者中23人(27.4%)检出共35个突变,供者10/42(23.8%)和受者13/42(31%)存在CH。
- CH与供者及受者年龄较大相关。
- 发现5例供者来源CH植入,其中1例供受者均进展为骨髓增生异常综合征。
- 5例中4例受者克隆大小较供者增加。
- CH克隆在髓系持续存在,B/T细胞穿透性不一;多突变者集落形成单位显示克隆演变或独立克隆;粒细胞端粒缩短提示受者HSC增殖史较供者约增加20年。
临床怎么用
- 亲属allo-HSCT长期随访中可关注供者来源CH的植入与克隆演变,尤其高龄供者。
局限性
- 研究样本量较小(42对),随访时间跨度大,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clonal hematopoiesis (CH) is associated with age and an increased risk of myeloid malignancies, cardiovascular risk, and all-cause mortality. We tested for CH in a setting where hematopoietic stem cells (HSCs) of the same individual are exposed to different degrees of proliferative stress and environments, ie, in long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their respective related donors (n = 42 donor-recipient pairs). With a median follow-up time since allo-HSCT of 16 years (range, 10-32 years), we found a total of 35 mutations in 23 out of 84 (27.4%) study participants. Ten out of 42 donors (23.8%) and 13 out of 42 recipients (31%) had CH. CH was associated with older donor and recipient age. We identified 5 cases of donor-engrafted CH, with 1 case progressing into myelodysplastic syndrome in both donor and recipient. Four out of 5 cases showed increased clone size in recipients compared with donors. We further characterized the hematopoietic system in individuals with CH as follows: (1) CH was consistently present in myeloid cells but varied in penetrance in B and T cells; (2) colony-forming units (CFUs) revealed clonal evolution or multiple independent clones in individuals with multiple CH mutations; and (3) telomere shortening determined in granulocytes suggested ∼20 years of added proliferative history of HSCs in recipients compared with their donors, with telomere length in CH vs non-CH CFUs showing varying patterns. This study provides insight into the long-term behavior of the same human HSCs and respective CH development under different proliferative conditions.
引用
- Boettcher S, Wilk CM, Singer J, et al. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation. Blood. 2020. PMID: 32181816. doi:10.1182/blood.2019003079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。